CPT 89325: Sperm Antibody Test in Semen or Serum
Commercial payers pay $20 on average nationally for this procedure.
CPT code 89325 describes a laboratory immunologic test to detect sperm antibodies in a specimen (for example, male semen or female serum) used to evaluate infertility; the service is a clinical laboratory pathology procedure typically performed in a hospital or independent clinical laboratory setting as a diagnostic test for reproductive dysfunction.
For related coverage guidance, see recent payer policy updates: Minimal Residual Disease (MRD) Testing for Cancer, Biomarker Testing Mandate, Prenatal (Fetal) Diagnostic Testing.
Customize your policy alerts
Sign up for cpt 89325 policy alerts
Get alerted when payer policies referencing 89325 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
National commercial reimbursement for CPT 89325 centers on a BUCA average commercial rate of $20.4, with individual payer medians clustering below that average for some carriers and above for others. Blue Cross Blue Shield shows the highest variability and highest median among the listed payers, while Aetna and UnitedHealth Group sit at lower medians, reflecting a mixed market where payers span a broad band of pricing around the BUCA commercial mean.
Dispersion (P75 minus P25) highlights relative consistency for Aetna and UnitedHealth Group, each with a range of $4.9 and $6.4 respectively, while Blue Cross Blue Shield and Cigna exhibit the widest spreads at $8.0 and $9.6 respectively, indicating greater within-payer rate variation. BUCA’s interquartile span is $7.9, placing it between the tightest and widest payers and reflecting a moderate level of commercial rate dispersion.